This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n22http://linked.opendata.cz/ontology/domain/vavai/riv/typAkce/
dctermshttp://purl.org/dc/terms/
n19http://purl.org/net/nknouf/ns/bibtex#
n17http://localhost/temp/predkladatel/
n20http://linked.opendata.cz/resource/domain/vavai/projekt/
n8http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n12http://linked.opendata.cz/resource/domain/vavai/subjekt/
n11http://linked.opendata.cz/ontology/domain/vavai/
n15https://schema.org/
shttp://schema.org/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/
skoshttp://www.w3.org/2004/02/skos/core#
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F68407700%3A21460%2F11%3A00184599%21RIV13-MSM-21460___/
n6http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n21http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n18http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F68407700%3A21460%2F11%3A00184599%21RIV13-MSM-21460___
rdf:type
skos:Concept n11:Vysledek
dcterms:description
Health Technology Assessment (HTA) comprises a number of various methods utilized to assess health technologies. Medical devices constitute a large area of interest for HTA. As an example of a comprehensive HTA methodology, clinical and economic effectiveness of targeted preventive of breast cancer (for women with the BRCA1/2 gene mutation) is studied on a sample of 105 women included in the program against a control group of 91 patients (with the same gene mutation). Generally, there is not much interest in HTA results in the Czech Republic. Basic reasons and prospects are discussed. At present, the question of assessing a particular medical device purchased or to be purchased is topical in the Czech Republic. The situation is quite cloudy, as each installation differs both in its technical specification, and in sale and guarantee terms and conditions. Moreover, there is an ambiguous role of consolidating dealers in a market, where no price list exist. Health Technology Assessment (HTA) comprises a number of various methods utilized to assess health technologies. Medical devices constitute a large area of interest for HTA. As an example of a comprehensive HTA methodology, clinical and economic effectiveness of targeted preventive of breast cancer (for women with the BRCA1/2 gene mutation) is studied on a sample of 105 women included in the program against a control group of 91 patients (with the same gene mutation). Generally, there is not much interest in HTA results in the Czech Republic. Basic reasons and prospects are discussed. At present, the question of assessing a particular medical device purchased or to be purchased is topical in the Czech Republic. The situation is quite cloudy, as each installation differs both in its technical specification, and in sale and guarantee terms and conditions. Moreover, there is an ambiguous role of consolidating dealers in a market, where no price list exist.
dcterms:title
Health Technology Assessment and Medical Devices Health Technology Assessment and Medical Devices
skos:prefLabel
Health Technology Assessment and Medical Devices Health Technology Assessment and Medical Devices
skos:notation
RIV/68407700:21460/11:00184599!RIV13-MSM-21460___
n11:predkladatel
n12:orjk%3A21460
n4:aktivita
n21:S n21:P
n4:aktivity
P(NT11532), S
n4:dodaniDat
n18:2013
n4:domaciTvurceVysledku
n8:1354639 n8:2861380 Kneppo, Peter n8:5287936 n8:7964218
n4:druhVysledku
n13:D
n4:duvernostUdaju
n16:S
n4:entitaPredkladatele
n9:predkladatel
n4:idSjednocenehoVysledku
201797
n4:idVysledku
RIV/68407700:21460/11:00184599
n4:jazykVysledku
n10:eng
n4:klicovaSlova
Health Technology Assessment; clinical and economic effectiveness; breast cancer preventive; BRCA1/BRCA2; assessing medical devices; MRI 1.5T purchases
n4:klicoveSlovo
n6:BRCA1%2FBRCA2 n6:MRI%201.5T%20purchases n6:breast%20cancer%20preventive n6:Health%20Technology%20Assessment n6:assessing%20medical%20devices n6:clinical%20and%20economic%20effectiveness
n4:kontrolniKodProRIV
[839C488BDEDB]
n4:mistoKonaniAkce
Iasi
n4:mistoVydani
Iasi
n4:nazevZdroje
EHB 2011 Proceedings
n4:obor
n5:FS
n4:pocetDomacichTvurcuVysledku
5
n4:pocetTvurcuVysledku
5
n4:projekt
n20:NT11532
n4:rokUplatneniVysledku
n18:2011
n4:tvurceVysledku
Rogalewicz, Vladimír Kneppo, Peter Ujhelyiová, Alena Poušek, Lubomír Šinkorová, Veronika
n4:typAkce
n22:WRD
n4:wos
000304806300078
n4:zahajeniAkce
2011-11-24+01:00
s:numberOfPages
6
n19:hasPublisher
Gr. T. Popa University of Medicine and Pharmacy
n15:isbn
978-1-4577-0292-1
n17:organizacniJednotka
21460